Frederic Cedrone, PhD profile page

Dr. Frederic Cedrone is vice president, corporate innovation at Catalent, a global development and manufacturing leader in enabling biopharma, cell, gene and consumer health partners. Cedrone works closely with Catalent’s Cell and Gene Therapy teams, as well as external partners to leverage innovations in the development of emerging therapeutic modalities, through in & out licensing, partnerships development and technologies acquisition. Cedrone joined Catalent in 2022, with 18 years of biotech experience in biologic drug development, including cell and gene therapies. Cedrone joined Catalent from Lysogene SA, Paris, France, where he held the role of vice president, alliances & business development. Prior to Lysogene, Cedrone worked at Cellectis SA, where he held several senior roles, both as a scientist and in business development, partnerships and licensing in the field of gene editing and Allo CARTs. Cedrone earned a PhD in molecular biology and enzyme engineering from Marseille University, France, an engineer’s degree in biotechnology and a Master of Science in molecular genetics from Blaise Pascal University in Clermont-Ferrand, France.